Xiangya Hospital Central South University

Site:	Xiangya Hospital Central South University
Address:
City:	Changsha
State:	Hunan
Zip:	410013
Country:	China

Phase [desc]	Trial	Trial Status	Site Status	Drug	NCT#
2/3	A Multicenter, Open-label Clinical Study to Evaluate the Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) (GISTAR-1)	Not yet recruiting	Not yet activated	NB003	NCT07379047
1	A Study of NB003 in Patients With Advanced Malignancies	Active, not recruiting	Active	NB003	NCT04936178
	Apatinib Mesylate (Rivoceranib) Versus Standard Second-line TKI in the Treatment of Advanced GIST	Recruiting	Active	Apatinib Mesylate	NCT05751733